These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 24463469)

  • 21. JAK2 V617F positive polycythemia Vera in a child with neurofibromatosis type I.
    Berman JN; Greer WL; Archambeault S; Loh ML; Riddell C; Morash B; Dumas N; Fernandez CV; Ludman MD
    Pediatr Blood Cancer; 2008 Nov; 51(5):689-91. PubMed ID: 18623221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. JAK2 exon 12 mutations in polycythemia vera or idiopathic erythrocytosis.
    Martínez-Avilés L; Besses C; Alvarez-Larrán A; Cervantes F; Hernández-Boluda JC; Bellosillo B
    Haematologica; 2007 Dec; 92(12):1717-8. PubMed ID: 18056003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different involvement of the megakaryocytic lineage by the JAK2 V617F mutation in Polycythemia vera, essential thrombocythemia and chronic idiopathic myelofibrosis.
    Hussein K; Brakensiek K; Buesche G; Buhr T; Wiese B; Kreipe H; Bock O
    Ann Hematol; 2007 Apr; 86(4):245-53. PubMed ID: 17262192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polycythemia vera transforming to acute myeloid leukemia and complex abnormalities including 9p homogeneously staining region with amplification of MLLT3, JMJD2C, JAK2, and SMARCA2.
    Hélias C; Struski S; Gervais C; Leymarie V; Mauvieux L; Herbrecht R; Lessard M
    Cancer Genet Cytogenet; 2008 Jan; 180(1):51-5. PubMed ID: 18068534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalance of JAK2 V617F and exon 12 mutations in polycythaemia vera.
    Scott LM; Beer PA; Bench AJ; Erber WN; Green AR
    Br J Haematol; 2007 Nov; 139(3):511-2. PubMed ID: 17910642
    [No Abstract]   [Full Text] [Related]  

  • 26. Molecular pathogenesis and therapy of polycythemia induced in mice by JAK2 V617F.
    Zaleskas VM; Krause DS; Lazarides K; Patel N; Hu Y; Li S; Van Etten RA
    PLoS One; 2006 Dec; 1(1):e18. PubMed ID: 17183644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. JAK2(V617F) allele burden in polycythemia vera correlates with grade of myelofibrosis, but is not substantially affected by therapy.
    Silver RT; Vandris K; Wang YL; Adriano F; Jones AV; Christos PJ; Cross NC
    Leuk Res; 2011 Feb; 35(2):177-82. PubMed ID: 20650526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phenotypic variations and new mutations in JAK2 V617F-negative polycythemia vera, erythrocytosis, and idiopathic myelofibrosis.
    Williams DM; Kim AH; Rogers O; Spivak JL; Moliterno AR
    Exp Hematol; 2007 Nov; 35(11):1641-6. PubMed ID: 17920755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concurrent JAK2(V617F) mutation and MTHFR(C677T) homozygosity in an adolescent with polycythemia vera: case report and discussion.
    Ehmann MR; Goodenough CJ; Lotterman CD; Warrier RP
    Clin Pediatr (Phila); 2013 Jul; 52(7):671-4. PubMed ID: 22626845
    [No Abstract]   [Full Text] [Related]  

  • 30. [Mutation of protein kinase JAK2 in polycythemia vera: new perspectives in physiopathology and therapy].
    Marie I; Hervé F
    Rev Med Interne; 2006 Jun; 27(6):473-7. PubMed ID: 16631280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. JAK2 V617F mutation is rare in idiopathic erythrocytosis: a difference from polycythemia vera.
    Yoshinaga K; Mori N; Wang YH; Tomita K; Shiseki M; Motoji T
    Int J Hematol; 2008 Jul; 88(1):82-87. PubMed ID: 18528646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A resequencing program in India detects the rare JAK2 L579F mutation in patients suffering from polycythemia vera and negative for JAK2 V617F.
    Acharya A; Vaniawala S; Parekh H; Sheikh H; Patel H; Ali R; Khan A; Nagee A; Kunjadia P; Mukhopadhyaya PN
    Int J Lab Hematol; 2014 Aug; 36(4):e30-3. PubMed ID: 24033912
    [No Abstract]   [Full Text] [Related]  

  • 33. The JAK2(V617F) tyrosine kinase mutation in blood donors with upper-limit haematocrit levels.
    Tagariello G; Di Gaetano R; Sartori R; Zanotto D; Belvini D; Radossi P; Risato R; Roveroni G; Salviato R; Tassinari C; Toffano N
    Blood Transfus; 2009 Apr; 7(2):111-6. PubMed ID: 19503632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decrease in JAK2 V617F allele burden is not a prerequisite to clinical response in patients with polycythemia vera.
    Kuriakose E; Vandris K; Wang YL; Chow W; Jones AV; Christos P; Cross NC; Silver RT
    Haematologica; 2012 Apr; 97(4):538-42. PubMed ID: 22102708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of thrombosis in patients with essential thrombocythemia and polycythemia vera according to JAK2 V617F mutation status.
    Finazzi G; Rambaldi A; Guerini V; Carobbo A; Barbui T
    Haematologica; 2007 Jan; 92(1):135-6. PubMed ID: 17229651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. B-cell acute lymphoblastic leukemia in JAK2 V617F-positive polycythemia vera.
    Jaitly V; Wang W
    Blood; 2018 Feb; 131(8):941. PubMed ID: 29472375
    [No Abstract]   [Full Text] [Related]  

  • 37. Mutations in exon 12 of JAK2 are mainly found in JAK2 V617F-negative polycythaemia vera patients.
    Kouroupi E; Zoi K; Parquet N; Zoi C; Kiladjian JJ; Grigoraki V; Vainchenker W; Lellouche F; Marzac C; Schlageter MH; Dosquet C; Scott LM; Fenaux P; Loukopoulos D; Chomienne C; Cassinat B
    Br J Haematol; 2008 Aug; 142(4):676-9. PubMed ID: 18503583
    [No Abstract]   [Full Text] [Related]  

  • 38. Modest contribution of JAK2 V617F allele burden to the occurrence of major thrombosis in polycthemia vera and essential thrombocythemia.
    Trifa AP; Bănescu C; Voina CM; Popa Ș; Török-Vistai T; Bojan AS; Dima D; Zdrenghea M; Fetica B; Vișan S; Tomuleasa C; Pârvu A; Urian L; Pop B; Popov VM; Andreescu M; Popp RA
    Blood Cells Mol Dis; 2018 Nov; 73():45-46. PubMed ID: 30249383
    [No Abstract]   [Full Text] [Related]  

  • 39.
    Sassi H; Menif S; Ammar SB; Farrah A; Othmen HBH; Amouri H
    Pan Afr Med J; 2021; 39():194. PubMed ID: 34603575
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of JAK2 exon 12 mutations in 15 patients with JAK2V617F negative polycythemia vera.
    Schnittger S; Bacher U; Haferlach C; Geer T; Müller P; Mittermüller J; Petrides P; Schlag R; Sandner R; Selbach J; Slawik HR; Tessen HW; Wehmeyer J; Kern W; Haferlach T
    Haematologica; 2009 Mar; 94(3):414-8. PubMed ID: 19252176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.